Public Company News
SOHU.COM REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 UNAUDITED FINANCIAL RESULTS
BEIJING, Feb. 9, 2026 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU) ("Sohu" or the "Company"), a leading Chinese online media platform and game business group, today reported unaudited financial results for the fourth quarter and fiscal year endedDecember 31, 2025. Fourth Quarter Highlights ...
2026-02-09 13:00
7811
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology
SAN FRANCISCO and SUZHOU, China, Feb. 8, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncologic, autoimmune, cardiovascular and metaboli...
2026-02-08 18:05
8541
Neurophet Secures FDA 510(k) Clearance for "Neurophet AQUA AD Plus," Marking Its Third U.S. Regulatory Milestone
* Following AQUA and SCALE PET, the latest FDA clearance reinforces Neurophet's leadership in AI-based Alzheimer's disease imaging analysis * Advanced analysis of neuroimaging features associated with cerebral microbleeds and edema supports imaging-based clinical decision-making and accelera...
2026-02-06 22:00
13253
The domestic service industry will continue to be exempt from value-added tax, and the 2026 tax reform will promote the sustainable and high-quality development of China's domestic service sector
FUZHOU, China, Feb. 6, 2026 /PRNewswire/ -- E-Home Household Services Holdings Limited (NASDAQ:EJH) (the "Company" or "eHome"), an integrated home services provider inChina, announced today that the company will fully leverage new tax incentives to enhance financial management, strengthen trainin...
2026-02-06 21:30
8937
Insilico Medicine Appoints Halle Zhang, PhD (Med), as Vice President, Clinical Development - Oncology
CAMBRIDGE, Mass., Feb. 6, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico") (3696.HK), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), today announced the appointment ofHalle Zhang, PhD (Med), as Vice President, Clinical Development – Oncology. Dr. Z...
2026-02-06 21:00
8900
Samsung Biologics leads climate transparency with independent validation of Product Carbon Footprint system
* Samsung Biologics' PCF system validated in line with globally established ISO and PAS standards * Validation reflects continued efforts to establish credible carbon accounting in support of net-zero goals * Validated system provides reliable, consistent carbon footprint data for clients I...
2026-02-06 21:00
11965
MicroCloud Hologram Inc. Develops GHZ State and W State Transmission Scheme Based on Brownian State Quantum Channel
SHENZHEN, China, Feb. 6, 2026 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, developed a transmission scheme for GHZ states and W states based on Brownian state quantum channels. This scheme establishes an efficient transmission ...
2026-02-06 21:00
11548
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
BEIJING, Feb. 6, 2026 /PRNewswire/ -- LakeShore Biopharma Co., Ltd ("LakeShore Biopharma" or the "Company") (OTCPK: LSBCF; OTCPK: LSBWF), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics fo...
2026-02-06 20:00
11349
Appotronics Wins Best of Show Award at ISE 2026: Redefining AV Technology
Best of Show Award: Redefining AV Technology BARCELONA, Spain, Feb. 6, 2026 /PRNewswire/ -- Appotronics, a global leader in laser display technology, announced that its product has been honored with the 2026 ISE Best of Show Award in the AV Technology category. Selected and presented by Future's...
2026-02-06 17:03
7045
PharmaResearch Receives U.S. FDA Clearance to Initiate Phase 1 Clinical Trial of Nano Anticancer Drug, PRD-101
SEONGNAM, South Korea, Feb. 6, 2026 /PRNewswire/ -- PharmaResearch Co., Ltd. (CEO:Jihoon Sohn) today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for PRD-101, enabling the initiation of a Phase 1 clinical trial inthe United ...
2026-02-06 15:20
7941
Akeso Receives Fifth Breakthrough Therapy Designation from NMPA for Ivonescimab in First-Line Treatment of Advanced Biliary Tract Cancer
HONG KONG, Feb. 5, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) is pleased to announce that ivonescimab, its global first-in-class bispecific antibody targeting PD-1 and VEGF, has been granted its fifth Breakthrough Therapy Designation from the Center for Drug Evaluation (CDE) of the National Medic...
2026-02-06 10:26
9221
e-STORAGE and Sunraycer Announce 503 MWh Battery Energy Storage Projects in Texas
KITCHENER, ON, Feb. 5, 2026 /PRNewswire/ -- Canadian Solar Inc.
2026-02-05 22:00
7489
Jin Medical CEO Fireside Chat
CHANGZHOU, China, Feb. 5, 2026 /PRNewswire/ -- Jin Medical International Ltd. (NASDAQ:ZJYL) ("Jin Medical", and together with all its subsidiaries, the "Company"), a NASDAQ-listed leading provider of rehabilitation medical equipment hosted a CEO Fireside Chat onFebruary 2, 2026 where the CEO sha...
2026-02-05 21:57
8743
Massimo Group Showcases MVR HVAC Pro Series at the GCSAA Conference, Accelerating Dealer, Fleet and International Expansion
GARLAND, Texas, Feb. 5, 2026 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and advanced electric mobility solutions, today announced its participation in the 2026 Golf Course Superintendents Association of America Conference and Trade Show, t...
2026-02-05 21:00
8243
Insilico Medicine Nominates ISM5059, the Peripheral-restricted NLRP3 Inhibitor as Preclinical Candidate, for the Treatment of Multiple Inflammatory and Metabolism Indications
* NLRP3 is a validated anti-inflammatory target that mediates the release of proinflammatory cytokines IL-1β and IL-18, and ISM5059 targets systemic inflammatory conditions by targeting NLRP3 and blocking the inflammatory cascade at its source. * Unlike ISM8969, Insilico's brain-penetrant NLR...
2026-02-05 21:00
8304
A Subsidiary of AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C to Serve as an Event Coordinator for 2026 Middle East Consumer Electronics Show
DUBAI, UAE, Feb. 5, 2026 /PRNewswire/ -- AMBITIONS ENTERPRISE MANAGEMENT CO. L.L.C ("Ambitions" or "the Company") (NASDAQ: AHMA), a UAE-based MICE (meetings, incentives, conferences, and exhibitions) and tourism services provider, today announced that its wholly-owned subsidiary, MULTIPLE EVENTS ...
2026-02-05 20:30
10933
Cloopen Announces Changes to Board of Directors and Committee Membership
BEIJING, Feb. 5, 2026 /PRNewswire/ -- Cloopen Group Holding Limited (OTC: RAASY) ("Cloopen" or the "Company") today announced that its Board of Directors (the "Board") has approved resolutions regarding changes to the composition of the Board and the Compensation Committee, effectiveFebruary 5, 2...
2026-02-05 20:00
9693
Eisai and Henlius Enter into Exclusive Commercial License Agreement for Anti-PD-1 Antibody Serplulimab in Japan
TOKYO and SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Shanghai Henlius Biotech, Inc. (Headquarters:Shanghai, China, CEO: Jason Zhu, "Henlius") announced today the conclusion of an exclusive commercialization and co-exclusive developm...
2026-02-05 19:44
7823
HanchorBio Accelerates Global Clinical Footprint with Multiple Oral and Poster Presentations in Q1 2026
Sustained execution and high-impact data across HanchorBio's next-generation immuno-oncology portfolio to be featured at ASCO-GI, AACR-IO, ESMO-TAT, ICNHO, and WOC TAIPEI and SHANGHAI and SAN FRANCISCO, Feb. 4, 2026 /PRNewswire/ -- HanchorBio, Inc. (TPEx: 7827), a global clinical-stage biotechno...
2026-02-05 17:09
8997
Dingdong Announces Entry into Definitive Agreement to Sell its China Business to Meituan
SHANGHAI, Feb. 5, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited ("Dingdong" or the "Company") (NYSE: DDL), a leading fresh grocery e-commerce company inChina, today announced that it has entered into a definitive Share Purchase Agreement (the "Share Purchase Agreement") with Two Hearts Investmen...
2026-02-05 17:08
8870
Week's Top Stories
Most Reposted
Asia Pacific Travellers Seek Familiarity, Practicality, Flexibility Amid Shifting Global Dynamics: Visa Report
[Picked up by 326 media titles]
2026-06-16 10:00
Visa and Mintoak Join Forces to Bring Merchant SaaS Capabilities to Acquirers Across Asia Pacific
[Picked up by 312 media titles]
2026-06-17 11:00Tamas Szabo on Pepperstone's Competitive Mindset and the Power of F1
[Picked up by 293 media titles]
2026-06-16 17:40
Hyundai Card Reopens Korea's Kimchi Bond Market, Expands Funding Portfolio with Dual-Currency USD-CNY Issuance
[Picked up by 292 media titles]
2026-06-18 15:00
Carro enters Australia with CarPlace acquisition to bring better, transparent car buying and selling experience to Australians
[Picked up by 292 media titles]
2026-06-18 10:00
Most Read
51Talk Online Education Group Announces First Quarter 2026 Results
2026-06-12 19:00
10184
NYSE Content Update: Fifth Third Bancorp Celebrates Historic Listing Transfer
2026-06-12 21:08
9352
Cheche Group Announces Results of Extraordinary General Meeting
2026-06-12 20:30
7987
Church Leaders Join Mayor Linda Aitken in Prayer for WA's Fastest Growing City
2026-06-12 15:04
7448
